ArticleVeterinary research communications2026
Genomic analysis of Escherichia coli, Enterobacter hormaechei, and Cupriavidus gilardii isolated from Cacatua alba.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study was to perform genomic, phylogenomic, and phenotypic characterization of bacterial isolates from a captive Cacatua alba to investigate their antimicrobial resistance profiles, virulence-associated genes, and genomic relationships with publicly available strains. Bacterial isolates obtained from the lungs and encephalon were identified as Escherichia coli (AV037), Enterobacter hormaechei (AV038), and Cupriavidus gilardii (AV039). Comparative genomic analyses, phylogenomic reconstruction, and antimicrobial susceptibility testing (AST) were performed. Genomic analysis identified multiple antimicrobial resistance-associated genes in AV037, AV038, and AV039, with genes associated with efflux pumps, particularly those in the resistance-nodulation-cell division (RND) family, as the predominant resistance-associated mechanism identified. Most identified genes are intrinsic to the respective bacterial species and do not necessarily confer phenotypic antimicrobial resistance when present alone. Phenotypic testing confirmed multidrug-resistant (MDR) profiles, with resistance to β-lactams and aminoglycosides. Susceptibility to carbapenems was preserved in AV037 and AV038, whereas AV039 exhibited resistance to meropenem. Phylogenomic analysis demonstrated that AV037 and AV038 clustered with strains recovered from diverse hosts and geographic regions. In contrast, AV039 clustered predominantly with environmental and human-associated isolates, including strains harboring the mcr-5 gene. These findings are consistent with previous reports describing the recovery of C. gilardii from both environmental and clinical sources. Overall, this study documents the occurrence of MDR bacteria carrying resistance and virulence-associated determinants in a captive C. alba, highlighting the value of genomic surveillance to improve our understanding of the distribution of clinically relevant bacterial isolates across different ecological settings.
Indexed as
Identifiers
42667506What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.